- Home
- DXR vs GEG Comparison
DXR vs GEG Comparison
Compare DXR & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DXR | GEG |
|---|---|---|
| Founded | 1970 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.0M | 67.4M |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DXR | GEG |
|---|---|---|
| Price | $11.45 | $2.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 40.0K | 10.3K |
| Earning Date | 02-27-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,446,345.00 | ★ $67,974,000.00 |
| Revenue This Year | $44,935.22 | N/A |
| Revenue Next Year | $74.79 | N/A |
| P/E Ratio | $33.83 | ★ N/A |
| Revenue Growth | N/A | ★ 11.70 |
| 52 Week Low | $8.56 | $1.80 |
| 52 Week High | $14.76 | $2.97 |
Technical Indicators
Market Signals| Indicator | DXR | GEG |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 44.33 |
| Support Level | $9.43 | $2.09 |
| Resistance Level | $12.08 | $2.22 |
| Average True Range (ATR) | 0.76 | 0.05 |
| MACD | 0.12 | -0.00 |
| Stochastic Oscillator | 65.96 | 5.26 |
Price Performance
Historical ComparisonAbout DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.